Casdin Capital’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.31M Sell
758,857
-187,500
-20% -$2.3M 0.85% 17
2025
Q1
$10.4M Buy
+946,357
New +$10.4M 0.85% 21